Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF5Q3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,311
Award facts
- Contract value 100% obligated
- $11,311.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 23, 2026, for Dupixent (dupilumab) 300 mg/2 mL pen injectors, with a firm fixed price ceiling of $11,311.26.
Place of performance is Conshohocken, PA. The ultimate completion date is March 24, 2026. This delivery order was issued under a non-competitive, firm fixed-price structure with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FF5Q3?
SPE2DR26FF5Q3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 23, 2026.
How much is contract SPE2DR26FF5Q3 worth?
The government has obligated $11,311 on SPE2DR26FF5Q3.
Is contract SPE2DR26FF5Q3 an order under another contract?
Yes. SPE2DR26FF5Q3 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FF5Q3 competed?
The extent of competition for SPE2DR26FF5Q3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award